The Angioshield Study Feasibility II

Inclusion Criteria: Subject will be eligible for inclusion in the investigation if he/she: 1. is between the ages of 18 and 80 years of age, inclusive 2. requires CABG surgery due to atherosclerotic coronary artery disease with minimum of two SVGs, one used to bypass a stenosis in the main Right Coronary artery and one used to bypass a stenosis in the Circumflex artery territory 3. is able to give their informed written consent 4. is willing and able to complete all follow-up visits and procedures 5. is to be treated via a medial sternotomy with cardio-pulmonary bypass during surgery 6. has adequate saphenous veins 7. Is a candidate for transcatheter therapy, PCI Exclusion Criteria: Subject will be excluded from participation in the investigation if he/she: 1. is currently enrolled in another clinical investigation 2. is unable to tolerate or comply with required post-surgical medications or imaging (e.g., anticoagulation regimen; or known allergy to contrast agent) 3. is or may be pregnant or is lactating, or plans to become pregnant in the next 12 months 4. history of a hypercoagulable state 5. has had an acute MI within the last 21 days 6. has had a previous CABG 7. requires emergency surgery 8. has a left ventricular ejection fraction (LVEF) less than 35 % 9. has a target vessel stenosis of less than 75% 10. has a transmural infarct of the target artery territory 11. has a serum creatinine greater than 1.5 mg/dL 12. is having concomitant -surgery of any kind 13. has had previous saphenectomy (See inclusion) 14. has saphenous vein sizes incompatible with treatment range (i.e., \<3.5 mm or \>5 mm inner diameter) 15. limb Ischemia or non-healing ulcer 16. has moderate to severe COPD defined as FEV 1 of less than 1 liter 17. has had a CVA in last 90 days 18. has diffuse disease in target vessel with an inadequate anastomotic touchdown site